BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

3.08
Delayed Data
As of Sep 13
 -0.07 / -2.22%
Today’s Change
2.49
Today|||52-Week Range
9.95
-61.83%
Year-to-Date
No recent news for BioCryst Pharmaceuticals Inc.

Today’s Trading

Previous close3.15
Today’s open3.16
Day’s range3.01 - 3.20
Volume845,161
Average volume (3 months)2,088,781
Market cap$342.4M
Data as of 4:00pm ET, 09/13/2019

Growth & Valuation

Earnings growth (last year)-25.81%
Earnings growth (this year)-27.17%
Earnings growth (next 5 years)+19.86%
Revenue growth (last year)-18.00%
P/E ratioNM
Price/Sales40.32
Price/Book6.93

Competitors

 Today’s
change
Today’s
% change
REPLReplimune Group Inc+0.29+2.39%
PRTAProthena Corporation...-0.30-3.44%
XBITXBiotech Inc+0.63+6.95%
PTGXProtagonist Therapeu...+0.30+2.07%
Data as of 4:00pm ET, 09/13/2019

Financials

Next reporting dateNovember 6, 2019
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$20.7M
Annual profit (last year)-$101.3M
Net profit margin-490.25%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Vice President-Investor Relations &
Operations
Robert Bennett
Corporate headquarters
Durham, North Carolina

Forecasts